je.st
news
Tag: health care
Drug manufacturer must pay $125M in health care fraud case
2016-04-16 02:35:06| Biotech - Topix.net
" A federal judge in Boston has ordered the former pharmaceutical company Warner Chilcott to pay $125 million to resolve criminal and civil claims in a health care fraud case. U.S. District Judge F. Dennis Saylor IV imposed the sentence Friday, six months after the company pleaded guilty in connection with a scheme to illegally promote its drugs.
US stocks rise as health care and energy companies soar
2016-04-07 04:46:03| Biotech - Topix.net
U.S. stocks broke a two-day losing streak Wednesday as investors bought up drugmakers and other health care companies. Energy companies also jumped as the price of oil surged.
Tags: health
care
companies
energy
Zacks Investment Research Downgrades Sabra Health Care REIT Inc (SBRA) to Hold
2016-01-04 08:29:40| Apparel - Topix.net
According to Zacks, "Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in real estate serving the healthcare industry. The trust owns nursing homes, rehabilitation centers, assisted living facilities, and independent living centers.
Tags: health
research
care
hold
NuShield Provides Health Care Facilities with Germ Fighting Solution Technology
2015-12-01 11:31:08| Industrial Newsroom - All News for Today
NEWTOWN, Pa. - NuShield, Inc., an industry leader in LCD screen protection and glare-elimination technology, is providing a vital solution to health care facilities that are using mobile and stationary computer technology as part of their patient monitoring or electronic documentation system. A study in 2013 by the...
Tags: health
technology
care
solution
KEYTRUDA (pembrolizumab) Receives New Draft Recommendation from National Institute for Health and Care Excellence (NICE) in U.K. for First-Line Treatment for Advanced Melanoma
2015-10-09 13:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KEYTRUDA is Currently Approved in 39 Countries, including the United States and throughout the European Union KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the National Institute for Health and Care Excellence (NICE) of the United Kingdom (U.K.) has issued a draft recommendation, in the form of a Final Appraisal Determination (FAD), recommending KEYTRUDA (pembrolizumab) as a first-line treatment option for adults with advanced melanoma. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orAn Phan, 908-236-1130orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: for
advanced
health
care
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »